ライフサイエンスコーパス: negative result

1 tis diagnoses (both false positive and false negative results).

2 between a false-positive result and a false-negative result.

3 reduced the need for repeat testing after a negative result.

4 than lack of forebrain access, underlies the negative result.

5 ere six false-positive results and one false-negative result.

6 level in the surveillance of patients with a negative result.

7 ikely to have confirmed IC than those with a negative result.

8 nfit newly diagnosed, patients risks falsely negative results.

9 ay, although all conventional tests provided negative results.

10 sting interval to 3 years if both tests have negative results.

11 Special stains for organisms demonstrated negative results.

12 ical potential but give high levels of false-negative results.

13 antities because of the high number of false-negative results.

14 to organism ID, AST report, and preliminary negative results.

15 RA binding experiments with this domain gave negative results.

16 ies but can lead to false-positive and false-negative results.

17 e-positive results, and 44 (73%) had 0 false-negative results.

18 atalyze the reverse direction to avoid false negative results.

19 levels were independent predictors of false-negative results.

20 y, more toxic Hg species were evaluated with negative results.

21 stains for an infectious cause demonstrated negative results.

22 ecurrent HCV RNA-positive tests after serial negative results.

23 fungal cultures produce high rates of false-negative results.

24 m swabs of cutaneous lesions and often yield negative results.

25 resolvable isolates, with only 2 unexpected negative results.

26 should include the corpus for avoiding false negative results.

27 , reducing risks of false positive and false negative results.

28 reased potential for indeterminate and false-negative results.

29 adjudication of discrepant GDH-positive/CDT-negative results.

30 ed for mutations by using a microarray, with negative results.

31 ets and to identify false-positive and false-negative results.

32 tient race or class status yielded similarly negative results.

33 acute traumatic coagulopathy, with 29% false-negative results.

34 short follow-up duration contributed to the negative results.

35 body, rituximab, in SLE, reported unexpected negative results.

36 y product inhibition or by Akt1 binding gave negative results.

37 overall, but did not modify or confound the negative results.

38 ransport to the laboratory may lead to false-negative results.

39 to topical treatment to avoid possible false-negative results.

40 ent of positive results and 38% agreement of negative results.

41 e, Dsg1 negative) with pemphigus sera showed negative results.

42 ng, and five isolates (1.3%) generated false-negative results.

43 A receiving antifungal prophylaxis had false-negative results.

44 potential to reduce false-positive and false-negative results.

45 culture for CMV had both false-positive and -negative results.

46 d HIV subtype were not associated with false-negative results.

47 pe claim on an independent set of data, with negative results.

48 More than 99% had clear negative results.

49 h positive CSF hCMV-PCR and 115 (84.6%) with negative results.

50 spatial attention tasks have mostly yielded negative results.

51 ing in increases in false-positive and false-negative results.

52 ult in weak antibody binding and cause false-negative results.

53 nts are often hampered by false positive and negative results.

54 Only 6 RCTs (6.5%) reported negative results.

55 potentially causing false-positive and false-negative results.

56 s, BiFC can produce false positive and false negative results.

57 mised trials in drug resistant epilepsy with negative results.

58 25 of 25 true-negative samples (100%) showed negative results.

59 %; P < 0.01), with an equivalent increase in negative results.

60 ed from the transfer inoculum to avoid false-negative results.

61 AS pharyngitis and obviate backup testing on negative results.

62 positive results per volume in patients with negative results.

63 ve results (1.7%) and 3 N. gonorrhoeae false-negative results (0.3%), while Combo2 had none.

64 Rates of false-negative results (1.0 to 1.5 per 1000 women) and recomme

65 verall, ProbeTec had 17 C. trachomatis false-negative results (1.7%) and 3 N. gonorrhoeae false-negat

66 Of 700 examinations, 205 had negative results (117 of 350 in the FI group and 88 of 3

67 tests in 106 unique patients with an initial negative result, 134 (92.4%) tests and 98 (92.5%) patien

68 Most of the patients with false-negative results (18/19) were classified as inactive chr

69 69 subjects with PDFF values less than 5.0% (negative result), 22 were determined to have steatosis b

70 Of 8,227 individuals with a negative result, 4.4% (n = 361) converted their QFT resu

71 Of 115 specimens with indeterminate or negative results, 46.1% (n = 53) were B. pertussis posit

72 While LA yielded more false negative results (5/56) this did not reach statistical s

73 were as follows: 336 participants (54%) had negative results, 96 participants (15%) had atypical squ

74 current or persistent EMPD; causes for false-negative results according to their location, histopatho

75 The percentages of negative results among 398 women without >or= CIN2 were

76 d test results, including 13 with an initial negative result and 15 with an initial positive result.

77 eating C. difficile tests within 2 days of a negative result and limiting repeat testing to >/=1 week

78 68 (75.6%) were correct; there were 20 false-negative results and 2 false positives.

79 <100/muL, which accounted for 75.7% of false-negative results and 33.3% of PCR-detectable infections,

80 The 3-year PFS was 77% for patients with PET-negative results and 37.5% for patients with PET-positiv

81 Ten showed culture- and PCR-negative results and belonged to the periodontally healt

82 their potential for false-positive and false-negative results and for biases related to selection of

83 ing MR imaging may thus help to reduce false-negative results and improve risk assessment.

84 eral subsequent screening colonoscopies have negative results and no new cases of CRC are found in fa

85 ons to examine the association between false-negative results and participant, clinical, and testing-

86 Rates of false-positive and false-negative results and recommendations for additional imag

87 ate-onset Pompe disease often leads to false-negative results and subsequent delays in identification

88 ography may receive false-positive and false-negative results and subsequent imaging and biopsies.

89 at PFGE is prone to false-positive and false-negative results and suggests the need for a new gold st

90 th Hybrid Capture 2 (HC2)-positive, cytology-negative results and who were age >/=30 years from Kaise

91 le to biopsy, may reduce problems with false negative results and, thereby, influence patient managem

92 techniques can rapidly (about 1 day) confirm negative results and/or identify false-negative chromato

93 were not found in 27 of 47 (57.4%) samples (negative results), and 3 of 47 (6.4%) showed inconclusiv

94 .1%) had nonosteoporotic T-scores (DXA false-negative results), and most (97%) had L1 or mean T12 to

95 25%) had a positive result, 81 (65.3%) had a negative result, and 12 (9.7%) had an indeterminate resu

96 4%) had positive RIBA results, 217 (29%) had negative results, and 52 (7%) had indeterminate results.

97 Clearance was defined as 3 consecutive negative results, and blips as isolated positive results

98 confidence: prior probability, risk of false negative results, and risk of false positive results.

99 se programs will need to be aware that false-negative results are a possibility.

100 ascular diseases ('puzzling subgroups'), and negative results are easily misinterpreted.

101 Rates of false-negative results are low.

102 trials are widely hailed, while trials with negative results are often interpreted as scientific fai

103 We find that unless a sufficient fraction of negative results are published, false claims frequently

104 Only studies predating 1990 reported negative results as a result of insufficient magnitude o

105 timate of the 'true' TE by controlling false negative results associated with excessively high placeb

106 bsequently identified in the subgroup with a negative result at CT angiography.

107 f Radiology breast density category 4) and a negative result at mammography (Breast Imaging Recording

108 fects of re-treatment, the percentage of UBT-negative results at 1 year was 72.4% (95% CI, 69.9%-74.8

109 g-detected cancers, and 52 examinations with negative results at 1-year follow-up.

110 ac disease among first degree relatives with negative results at a first screening.

111 ere both significantly associated with false-negative results at abdominal radiography (P = .004 and

112 ies and the need for retesting patients with negative results at baseline.

113 ERs with positron emission tomography (PET) -negative results at response assessment.

114 False-positive or false-negative results attributable to undetected genotyping e

115 Should negative results become easier to publish as a claim app

116 TRAM flap reconstructions), 546 (98.6%) had negative results (Breast Imaging Reporting and Data Syst

117 fied as containing borderline color results (negative result but with no package insert color visible

118 ive result by culture (Nocardia species) but negative result by qPCR.

119 cription-PCR assay reduced the rate of false-negative results by 4% and reduced the rate of false-pos

120 he dot hybridization assay, but demonstrated negative results by culture, and 10 of the 11 samples we

121 Potential reasons for the negative results can be classified into three categories

122 sinolates and growth, this is likely a false negative result caused by the limited population size.

123 concentrations and risk of false positive or negative results caused by mixed spectra.

124 The positive- and negative-result concordance rates and overall concordanc

125 ducts that appear to transmit core antibody, negative results correlated with lower surface antibody

126 Generally, positive or negative results correlated with those obtained immunohi

127 either as a true negative result or a false negative result due to the absence or very low levels of

128 PV assay and should reduce the risk of false-negative results due to insufficient sample collection r

129 , clinical trials for RP treatments may give negative results due to multiple disease mechanisms with

130 ential for preventing the reporting of false-negative results due to the high-dose "hook" effect.

131 there was a single false-positive and false-negative result each, for a sensitivity and specificity

132 There were 2 cases of false-negative results each in the group with SDHB (2/12) and

133 This negative result explains why solvent additives mixtures

134 by enzyme immunoassay and PCR (i.e., initial negative result followed by positive result) within a 7-

135 previously negative ThinPrep vials yielded a negative result following routine automated cytology pro

136 ples containing Streptococcus pyogenes and a negative result for those without.

137 itivity in fewer than 5% of cells and showed negative results for adipophilin.

138 ls, squamous carcinomas and melanomas showed negative results for androgen receptors and adipophilin.

139 r prevalence of sIgE (>/=0.70 kU/L), whereas negative results for Ascaris lumbricoides, T gondii, her

140 nterval between screening colonoscopies with negative results for average-risk individuals.

141 amous carcinomas and melanomas, which showed negative results for both, and from basal cell carcinoma

142 opsy for cancer cases, 1-year follow-up with negative results for cases with negative findings) were

143 positivity for S4, or both, as compared with negative results for CMV and S4, were associated with an

144 en (43.8%) with positive and 42 (20.3%) with negative results for HCMV DNAemia (P = .006; odds ratio,

145 d were classified as cases and 117 (59%) had negative results for HIV and were classified as controls

146 her exact test) compared with tumors showing negative results for HPV-16.

147 Among the 78 subjects with negative results for intakes at home, 92% had no symptom

148 Most vitrectomies showed negative results for malignancy: 99.47% of TMC cases, 99

149 as MSSA by the BD Max StaphSR assay, due to negative results for MREJ.

150 an overestimation of response (yielded false-negative results for residual disease) in 66.7% (14 of 2

151 In both cases, analyses yielded negative results for strain-specific tests targeting cir

152 Negative results for Toxoplasma gondii were associated w

153 ) and the Physician's Health Study II showed negative results for vitamin E, vitamin C, and selenium

154 The often negative results for WNV by current RT-PCR and serologic

155 hromboembolism can be excluded solely with a negative result from a plasma D-dimer test.

156 ify diagnoses of non-DMD disorders and false negative results from 1975 to July 12, 2015.

157 ded adults after blunt traumatic injury with negative results from a well-interpreted, high-quality C

158 ng number of reports about false positive or negative results from conventional cytotoxicity assays o

159 pg/mul and 0.2 ng/mul) was tested to confirm negative results from lysates.

160 Negative results from multiple phase III trials suggest

161 rs in blood and soil samples can cause false negative results from PCR-based clinical and forensic te

162 peripheral blood monocytes, despite constant negative results from tests for HCV RNA in serum.

163 tes intensified after the publication of the negative results from the Action to Control Cardiovascul

164 CIN3+, while women with HC-2 positive/HPV16-negative results had a much lower risk of 2.4%.

165 The 2 (68)Ga-THP-PSMA scans with negative results had only 1+/2+ staining.

166 Patients with negative results had the option to watch a post-test vid

167 Despite having negative results, HN.6 has contributed important data re

168 ion inhibitors, potentially leading to false-negative results if unrecognized.

169 e with instructions, providing a positive or negative result in 20 min.

170 broth culture enrichment resulted in 1 false-negative result in 68 (1.5%).

171 ccess in psoriasis and Crohn's disease but a negative result in relapsing-remitting multiple sclerosi

172 (2/12) and VHL mutations (2/19) and 1 false-negative result in the subgroup of patients with unknown

173 optosis, whereas expression of Drp1-dominant negative resulted in the restoration of pluripotency mar

174 6% of the time but proceeded despite phase 2 negative results in 10 cases.

175 results in 26% (five of 19 patients), false-negative results in 11% (two of 19 patients) and by guid

176 sentinel lymph node would have led to false-negative results in 19 of 475 (4%) of all patients and 1

177 in testing for vancomycin sensitivity showed negative results in 3 patients and was not performed in

178 atients with a prior negative result yielded negative results in 396 (97.5%) of 406 tests.

179 The criteria resulted in false-negative results in 8 (1.9%) patients, 6 of whom were bo

180 Of these patients, 17 (19%) had negative results in all molecular tests and were therefo

181 proach for urine screening and might produce negative results in as few as 3 h, with no downstream wo

182 There was no difference in positive and negative results in comparisons of fresh and stored samp

183 opneumoniae PCR assays could result in false-negative results in current PCR tests.

184 erformance and factors contributing to false-negative results in longitudinal studies, we examined re

185 After negative results in screening for mutations in candidate

186 d to reduce haploid MRA escape reduced false negative results in SGA-type analysis, resulting in >95%

187 Four patients with negative results in sIgE antibodies to CCDs had positive

188 act clearance mechanisms bring into question negative results in single-gene knockout mice.

189 PET/CT provided false-positive and false-negative results in six and three patients (PPV, 81% [26

190 Is other than the culprit PPI that displayed negative results in skin tests (n = 61) and diagnostic O

191 Specimens with indeterminate or negative results in the CDC PCR were tested using an alt

192 However, the risk of PET false-negative results in the presence of carbidopa is a conce

193 5%), and 77.8% (95% CI, 73.6%-81.6%) had UBT-negative results in the triple, sequential, and concomit

194 tion tests were performed to 4 cases who had negative results in the wheat + exercise test.

195 lihood of empirical therapy leading to false-negative results in these patients.

196 Toxicity assays yield negative results in three cell lines, suggesting that pr

197 ons, with 10 false-positive and only 2 false-negative, resulting in a lesion-based detection rate for

198 ems associated with false-positive and false-negative results, inconsistencies and low reactivity of

199 ss-reactivity have been reported and because negative results indicate tolerability.

200 lt of 33 (95% CI, 15.0-72.0) and an LR for a negative result is 0.08 (95% CI, 0.02-0.3).

201 This negative result is surprising, given the importance of t

202 respectively, suggesting that a positive or negative result is unable, on its own, to confirm or exc

203 uman papillomavirus (HPV)-positive, cytology-negative results is critical to the introduction of HPV

204 These negative results lead us to search for specific mechanis

205 w-up of reported pertussis patients with PCR-negative results leads to the detection of more true per

206 PET/CT result for tumor and those who had a negative result (log-rank, P < 0.0001), with a hazard ra

207 Apparent false-negative results may be attributed to allelic divergence

208 g of all producers of ESBLs and also falsely negative results may occur with isolates that coproduce

209 o date no experiment has employed the 'ideal negative result' measurements that are required for the

210 The negative results might be owing to the effects of smokin

211 esult converted to positive after an initial negative result (n = 12).

212 5.7%-63.0%), corresponding to 6 of 874 false-negative results (none met treatment criteria).

213 The rates of concordance of positive or negative results obtained following immediate incubation

214 s a mathematical approach to limit the false negative results occuring with the use of other normaliz

215 erval [CI], 99.1%-99.6%) with a mean time to negative result of 4.2 +/- 0.9 hours.

216 e for food allergen, and to be careful about negative result of prick test.

217 If this test result is negative, a false-negative result of the mutation analysis should be consi

218 confirmed GCA (group 1), and 28 patients had negative results of a temporal artery biopsy for GCA (gr

219 aving achieved viral suppression if they had negative results of at least 1 subsequent HCV RNA test.

220 Negative results of atherosclerosis-imaging tests, parti

221 Twenty-nine (31%) of 95 women with negative results of baseline tests became infected, for

222 can have a relapsing course providing false negative results of endoscopy and ultrasound if performe

223 After negative results of endoscopy and ultrasound, the diagno

224 rriers, and healthy control subjects who had negative results of rapid diagnostic tests.

225 ation and degradation, which may explain the negative results of several recent clinical trials.

226 Given the negative results of some confirmatory trials, clinicians

227 In patients with mastocytosis, the negative results of standard tests are reliable, because

228 HT signaling axis that help to interpret the negative results of the Baminercept trial and will guide

229 this issue of Blood, Petersdorf et al report negative results of the phase 3 study designed by the So

230 ioural, that have been used to alleviate the negative results of time-zone transitions, are reviewed.

231 Persons with a negative result on screening colonoscopy are recommended

232 months, the proportion of subjects who had a negative result on testing with the target dose (20g dri

233 False-negative results on 123I-MIBG scintigraphy and/or [18F]F

234 Thirty-six patients had negative results on 3D-PMB.

235 8% and 96.4%, respectively, among those with negative results on colonoscopy (P<0.001).

236 ad an undetectable HBV viral load, and 3 had negative results on HBsAg testing and had an undetectabl

237 cond-line imaging strategy for patients with negative results on initial imaging with CT/MRI.

238 False-negative results on prior MR studies were retrospectivel

239 ve CDI because they have minimal diarrhea or negative results on recent tests).

240 ilities to tell women with dense breasts and negative results on screening mammography to discuss sup

241 dividuals with normal small-bowel mucosa and negative results on serum antitransglutaminase and antie

242 atients, the treatment was continued despite negative results on standard (18)F-FDG PET and negative

243 vice versa, obtaining the second test after negative results on the first seems justified when detec

244 ention-to-treat population who initially had negative results on the skin-prick test, the prevalence

245 e target may be interpreted either as a true negative result or a false negative result due to the ab

246 nosis, especially when PCR is delayed, shows negative results, or is not available.

247 ive results compared with 104 (44%) after of negative results (p<0.0018).

248 their sisters than conclusive (positive/true negative) results (P = .03).

249 Although not conclusive, this initial negative result prompted us to probe unknown regulations

250 Collectively, these positive and negative results provide deeper insight into mechanisms

251 N. gonorrhoeae, concordance for positive and negative results ranged from 91.4% to 100% and 99.3% to

252 ed from 93.7% to 100%, while concordance for negative results ranged from 98.2% to 100%.

253 with FilmArray GI panel within 4 weeks of a negative result rarely changed the initial result, and t

254 on, we consider the possible reasons for the negative results regarding the progression of DR in the

255 data, including more frequent publication of negative results; replacement of expert opinion with har

256 east cancer is unclear because of high false-negative results reported in previous studies.

257 Analysis of 7 aspirates with false negative results revealed that 6 had a paucity of thyroi

258 This negative result should be interpreted in light of the st

259 n in patients with GCA giant cell arteritis -negative results ( TAB temporal artery biopsy subcohort

260 mucoperiosteal flap gave significantly more negative results than that of the less-demanding flaples

261 ve, false-positive, true-negative, and false-negative results) that could be found or calculated from

262 including the clinical implications of false-negative results), the exclusion of transmission effects

263 Despite the negative result, the trial does provide information that

264 r complete sequencing of the ABCA4 gene with negative results, the screening for disease-causing muta

265 concentration of 1.2 ng/mul is required for negative results to be reliable.

266 roficiency assessment suggested positive and negative results to be reliable.

267 CMF and 1 adult volunteer were found to have negative results to scGOS through SPTs and BATs.

268 on lipid-modification end points followed by negative results using clinical end points.

269 We also obtained similar negative results using small molecule inhibitors of the

270 and 88%, respectively, in patients with PET-negative results versus 47% and 62%, respectively, in pa

271 present (10 fungus, 1 Acanthamoeba) but had negative results via culture and light microscopy.

272 rval [CI], 3.4-47.0) and the median LR for a negative result was 0.19 (95%CI, 0.06-0.37).

273 among all women with HC2-positive, cytology-negative results was 4.6%.

274 The percentage of examinations with negative results was tabulated for both groups, and the

275 sitive results and 26 people with concordant negative results were analyzed via the highly multiplexe

276 ith aztreonam and carbapenems; subjects with negative results were challenged with escalating doses o

277 true- and false-positive and true- and false-negative results were extracted to fit a cross-tabulatio

278 False-negative results were found in 2 patients and occurred a

279 No false-negative results were found.

280 taminated sample evaluations showed no false negative results were generated from a variety of differ

281 the individual sample-positive/pooled sample-negative results were likely due to the M. tuberculosis

282 False-negative results were minimized in these test definition

283 xhibited low temporal variability, (b) false-negative results were not obtained, (c) the indoor air c

284 No false-positive or false-negative results were observed among 90 bacterial strain

285 Negative results were obtained for the 9-6 haplotype, th

286 marker peptides, no false-positive or false-negative results were obtained.

287 Two false-negative results were related to poorly differentiated d

288 Falsely negative results were seen with all methods, especially

289 False-negative results were usually associated with early infe

290 Additional tests, including negative results, were retrospectively collected.

291 rasitemia, and PfHRP-II tests can give false-negative results when P. falciparum strains do not expre

292 cently, there has been a growing interest in negative results, which has resulted in negation detecti

293 Among participants with UBT-negative results who had a 1-year follow-up UBT (n=1091)

294 .8%), there were larger proportions of false-negative results with 1.0 ml (29.4%; P = 0.2) and 1.2 ml

295 of normal human kidney, in contrast with the negative results with 20 control serum samples.

296 There were 49 cases of RDT false-negative results with a parasite density range of 40-54

297 Overall, these negative results with bupropion and risperidone are conc

298 Seven of the 1982 patients (0.4%) had false-negative results with the staged algorithm.

299 The AST systems showed false-negative results with varying numbers, misidentifying me

300 Repeat PCR for 293 patients with a prior negative result yielded negative results in 396 (97.5%)